U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06937112) titled '18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis' on April 18.
Brief Summary: Evaluate the safety of the novel FAP targeted molecular probe 18F-FAPI-YQ104 labeled with radioactive isotopes in clinical applications and verify its effectiveness in tumor diagnosis.
Study Start Date: April 10
Study Type: OBSERVATIONAL
Condition:
Lung Cancers
Pancreatic Cancer
Neuroendocrine Tumors
Thyroid Cancer
Intervention:
OTHER: PET-CT examination
Intravenous injection of 18F-FAPI-YQ104 for PET-CT examination
Recruitment Status: RECRUITING
Sponsor: Nanjing First Hospital, Nanjing Medical University
Information provided by...